Natixis’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-215,731
| Closed | -$12.7M | – | 1246 |
|
|
2023
Q4 | $12.7M | Buy |
+215,731
| New | +$12.7M | 0.09% | 170 |
|
|
2023
Q3 | – | Sell |
-3,500
| Closed | -$126K | – | 1140 |
|
|
2023
Q2 | $126K | Sell |
3,500
-28,209
| -89% | -$1.02M | ﹤0.01% | 766 |
|
|
2023
Q1 | $1.18M | Buy |
+31,709
| New | +$1.18M | 0.01% | 489 |
|
|
2022
Q4 | – | Sell |
-8,750
| Closed | -$611K | – | 1270 |
|
|
2022
Q3 | $611K | Buy |
+8,750
| New | +$611K | ﹤0.01% | 814 |
|
|
2022
Q1 | – | Sell |
-13,450
| Closed | -$1.97M | – | 1366 |
|
|
2021
Q4 | $1.97M | Buy |
+13,450
| New | +$1.97M | 0.01% | 777 |
|